Spirobarbital
| Clinical data | |
|---|---|
| Other names | 5-spiro-(2'-ethyl-3'-5'-dimethyl-cyclopentyl)barbituric acid |
| ATC code |
|
| Identifiers | |
| |
| CAS Number |
|
| UNII |
|
| CompTox Dashboard (EPA) | |
| Chemical and physical data | |
| Formula | C12H18N2O3 |
| Molar mass | 238.287 g·mol−1 |
| 3D model (JSmol) | |
| |
| (verify) | |
Spirobarbital is a barbiturate derivative developed by Eli Lilly in the 1940s.[1] It has hypnotic and sedative effects, and has a moderate potential for abuse.[2]
References
- ^ US 2561688, Doran WJ, Van Heyningen EM, "Spirobarbituric Acids", issued 24 July 1951, assigned to Eli Lilly and Company
- ^ Isbell H, Chruściel TL (1970). "Dependence liability of "non-narcotic" drugs". Bulletin of the World Health Organization. 43 (Supplement): 5–104. PMID 20718122.
Content Disclaimer
Informasi ini disarikan dari Wikipedia dan disajikan kembali untuk tujuan edukasi. Konten tersedia di bawah lisensi CC BY-SA 3.0. Kami tidak bertanggung jawab atas ketidakakuratan data yang bersumber dari kontribusi publik tersebut.
- The information displayed on this website is sourced in part or in whole from Wikipedia and has been adapted for the purpose of restating it. We strive to provide accurate and relevant information, however:
- There is no guarantee of absolute accuracy. Wikipedia is an open, collaborative project that can be edited by anyone, so information is subject to change.
- It is not intended to constitute professional advice. The content displayed is for informational and educational purposes only. For important decisions (e.g., medical, legal, or financial), please consult a professional.
- Content copyright. Wikipedia is licensed under the Creative Commons Attribution-ShareAlike License (CC BY-SA). This means that content may be reused with appropriate attribution and shared under a similar license.
- Responsible use. Any risk arising from the use of information from this website is entirely the responsibility of the user.